NCT04102267 - Extended Delivery of Bupivacaine Study in Herniorrhaphy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

September 3, 2018

Study Completion Date

October 26, 2018

Conditions

Analgesia

Interventions

DRUG

Bupivacaine liposome injectable suspension

Liposomal bupivacaine 266 mg via injection

DRUG

Bupivacaine HCl without epinephrine via continuous infusion

Bupivacaine HCl 300 mg via continuous infusion

Trial Locations (1)

Anaheim Clinical Trials, LLC, Anaheim